The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 15, 2015

Filed:

Jun. 11, 2014
Applicants:

The Regents of the University of Michigan, Ann Arbor, MI (US);

Vanderbilt University, Nashville, TN (US);

Inventors:

Jolanta Grembecka, Ann Arbor, MI (US);

Tomasz Cierpicki, Ann Arbor, MI (US);

Sunil Kumar Upadhyay, Ypsilanti, MI (US);

Shaun R. Stauffer, Brentwood, TN (US);

Rocco D. Gogliotti, Kingston Springs, TN (US);

Timothy J. Senter, Nashville, TN (US);

Assignees:

THE REGENTS OF THE UNIVERSITY OF MICHIGAN, Ann Arbor, MI (US);

VANDERBILT UNIVERSITY, Nashville, TN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/445 (2006.01); C07D 401/06 (2006.01); C07D 417/06 (2006.01); C07D 295/088 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 211/22 (2006.01); C07D 211/26 (2006.01);
U.S. Cl.
CPC ...
C07D 417/06 (2013.01); C07D 211/22 (2013.01); C07D 211/26 (2013.01); C07D 295/088 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01);
Abstract

The present invention relates generally to compounds that inhibit the binding of menin and MLL or MLL fusion proteins and methods of use thereof. In particular embodiments, the present invention provides compositions comprising piperidine-containing compounds and methods of use thereof to inhibit the interaction of menin with MLL oncoproteins (e.g., MLL1, MLL2, MLL-fusion oncoproteins), for example, for the treatment of leukemia, solid cancers, diabetes, and other diseases dependent on activity of MLL1, MLL2, MLL fusion proteins, MLL-PTD and/or menin.


Find Patent Forward Citations

Loading…